Synthetic Biology

Biotechnology makes up nearly 3 percent of the U.S. gross domestic product.

Next generation biotechnology, synthetic biology, is evolving so quickly that it’s definition hasn’t been completely agreed upon. The Wilson Center’s Synthetic Biology Project lists several definitions, among them this one from Stanford University’s Drew Endy:

“Our overall long term goal is to help make biology easy to engineer, an area of research sometimes known as synthetic biology.”

In other words, synthetic biology is a discipline that is making it easier to engineer biology.

The same way it’s said that every business must be a technology business, soon it will be said every business is a biotechnology business. Those businesses that do not embrace biotechnology will be left behind by their competitors.

The ability to understand a new, evolving technology – especially one that allows the manipulation and modification of life itself – can be a challenge. I’ve been hired by advertising, public relations, digital health startups, and Fortune 500 companies to help them understand the impact that synthetic biology – the next iteration of biotechnology – will have on their business. I’ve established an extensive network of academics, investors, researchers, and synthetic biology company founders who are on the front lines of disrupting business as we know it.

I co-authored What’s Your Bio Strategy? to help executives understand the impact engineered biology would have on their world.

If you want to learn more about how to assure your business will thrive in the age of engineered email me.

Recent Publications
John Cumbers, Karl Schmieder, What’s Your Bio Strategy? (2017). Pulp Bio Press.
Karl Schmieder. Interview: John Cumbers, SynBioBeta: Passionate Entrepreneurs Use Biology to Improve the World. (Link).
Karl Schmieder, Clara Andrew-Wani. Four Perspectives on Business Model Evolution in Synthetic Biology. (2014) Journal of Commercial Biotechnology. 20.3 (PDF).